HQH Stock Overview
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Abrdn Healthcare Investors Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$16.05 |
| 52 Week High | US$17.66 |
| 52 Week Low | US$14.31 |
| Beta | 0.74 |
| 1 Month Change | -3.83% |
| 3 Month Change | -5.42% |
| 1 Year Change | -7.06% |
| 3 Year Change | -35.13% |
| 5 Year Change | -18.03% |
| Change since IPO | 64.62% |
Recent News & Updates
HQH: Healthcare Fund With 11% Income And A High Discount
Mar 03HQH: Disappointing Track Record
Feb 04HQH: I Am Getting A 9.5% Yield On My Last Buy
Dec 19HQH: New Name But Same Risky Bets On Biotech
Nov 14Recent updates
HQH: Healthcare Fund With 11% Income And A High Discount
Mar 03HQH: Disappointing Track Record
Feb 04HQH: I Am Getting A 9.5% Yield On My Last Buy
Dec 19HQH: New Name But Same Risky Bets On Biotech
Nov 14HQH: Deep Discount Presents An Opportunity
Jul 03Tekla Healthcare Investors raises dividend by 7.7% to $0.42
Feb 15HQH: 50 Big-Yield Healthcare Stocks, These 3 Worth Considering
Dec 24Equity CEFs: What's Going On With Tekla's HQH And HQL?
Dec 08Tekla Healthcare Investors declines quarterly dividend by -2.5% to $0.39/share
Nov 16HQH: A Dividend Paymaster That Fails To Register Price Growth
Oct 20Tekla Healthcare Investors goes ex-dividend tomorrow
Aug 24Tekla Healthcare: 10% Yielding CEF Trading Below NAV
Jul 17Tekla Healthcare Investors: A Dividend Paymaster That Can Compensate For Poor Price Performance
Mar 30Tekla Healthcare Investors: Understanding The Mechanics Of Its 8.5% Yield
Jan 16Technical Update On HQH: Presenting An Opportunity
Oct 06HQH: Higher Valuation, But Still Appealing
Jul 31Where Fundamentals Meet Technicals: HQH (Revisited) - Yield 7.74%
Jul 08Evaluating CEFs: HQH Provides A Well-Covered Distribution In A Hot Sector
Jun 27HQH: An Overweight Biotech Fund, Paying 8%+ Distribution
Jan 14Tekla Healthcare Investors declares $0.05 special dividend
Dec 21Tekla Healthcare Investors declares $0.48 dividend
Nov 16HQH: Deep Discount Leads To High Yield
Nov 09Shareholder Returns
| HQH | US Capital Markets | US Market | |
|---|---|---|---|
| 7D | 1.7% | 1.9% | 1.0% |
| 1Y | -7.1% | 28.1% | 21.9% |
Return vs Industry: HQH underperformed the US Capital Markets industry which returned 31.6% over the past year.
Return vs Market: HQH underperformed the US Market which returned 24.9% over the past year.
Price Volatility
| HQH volatility | |
|---|---|
| HQH Average Weekly Movement | 2.0% |
| Capital Markets Industry Average Movement | 3.5% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: HQH has not had significant price volatility in the past 3 months.
Volatility Over Time: HQH's weekly volatility (2%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1986 | n/a | n/a | n/a |
Abrdn Healthcare Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the healthcare sector, including the biotechnology, medical devices, and pharmaceuticals industries. The fund primarily invests in growth stocks of small cap companies.
Abrdn Healthcare Investors Fundamentals Summary
| HQH fundamental statistics | |
|---|---|
| Market cap | US$812.53m |
| Earnings (TTM) | US$56.33m |
| Revenue (TTM) | US$10.29m |
14.4x
P/E Ratio78.9x
P/S RatioIs HQH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HQH income statement (TTM) | |
|---|---|
| Revenue | US$10.29m |
| Cost of Revenue | US$0 |
| Gross Profit | US$10.29m |
| Other Expenses | -US$46.04m |
| Earnings | US$56.33m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.11 |
| Gross Margin | 100.00% |
| Net Profit Margin | 547.37% |
| Debt/Equity Ratio | 0% |
How did HQH perform over the long term?
See historical performance and comparison